Why 3D pharmacology? Improved predictive accuracy and reduced downstream development costs
Come see why our 2D/3D cellular pharmacology services are a 21st century solution to the decades-old challenges of drug development
BIOENSIS’ 2D/3D pharmacology systems maintain the cellular interactions, signaling pathways and metabolic/physiologic gradients that occur in human tissue.
This allows small molecules and biologics to be evaluated in a microenvironment that more faithfully reflects the environment of human tissues. 3D pharmacology overcomes many of the limitations of 2D approaches and improves the predictive capabilities of preclinical pharmacology assays.